Open AccessEvaluation of Moxalactam with the BD Phoenix System for Detection of Methicillin Resistance in Coagulase-Negative Staphylococci
Author(s) -
H. Pupin,
H. Renaudin,
Olivier JoinLambert,
Cécile Bebear,
Françis Mégraud,
Philippe Lehours
Publication year - 2007
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00578-07
Subject(s) - moxalactam , cefoxitin , coagulase , microbiology and biotechnology , staphylococcus saprophyticus , latamoxef , staphylococcus , micrococcaceae , medicine , antibacterial agent , biology , staphylococcus aureus , antibiotics , cephalosporin , bacteria , genetics
The performance of moxalactam with the BD Phoenix system for the detection of methicillin resistance in coagulase-negative staphylococci was evaluated by use of a collection of 186 strains. Moxalactam was a better drug as an indicator of methicillin resistance formecA -positive strains than oxacillin and cefoxitin were. For strains other thanStaphylococcus saprophyticus , a moxalactam MIC >16 μg/ml was indicative of methicillin resistance.